Global SGLT2 Inhibitor Market Outlook: Size, Share, and CAGR...

σε πρόσθεσε στο άλλο

2026-03-27 12:13:49 - Μετάφραση -

Global SGLT2 Inhibitor Market Outlook: Size, Share, and CAGR Analysis of the Cardio-Renal-Metabolic (CRM) Era (2025–2032)

The therapeutic landscape for Type 2 Diabetes Mellitus (T2DM) and associated cardiovascular conditions has been revolutionized by Sodium-Glucose Cotransporter-2 (SGLT2) inhibitors. Primarily represented by Empagliflozin, Dapagliflozin, and Canagliflozin,Market this drug class has transitioned from simple glucose-lowering agents to essential treatments for Heart Failure (HF) and...

0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση